[1] FDA News Release, "FDA approves Sylvant for rare Castleman's disease," April 23, 2014.
[2] NIH, Genetic and Rare Diseases Information Center (GARD), Multicentric Castleman's Disease.
Sign-up to receive recall notices, medical news, and litigation updates.